Sign in
NUTRITIONAL INSULIN OR GLP-1 RECEPTOR AGONIST: CROSSROADS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
Journal article   Peer reviewed

NUTRITIONAL INSULIN OR GLP-1 RECEPTOR AGONIST: CROSSROADS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS

Rajesh Garg
Endocrine practice, Vol.23(11), pp.1357-1358
2017-11-01
PMID: 29190136

Abstract

Endocrinology & Metabolism Life Sciences & Biomedicine Science & Technology

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.26 Diabetes
1.26.42 Diabetes
Web Of Science research areas
Endocrinology & Metabolism
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details